Theme
Cell therapy
Engineered-cell medicines — CAR-T and next-generation cell therapies for cancer and autoimmune disease.
Cell therapies re-engineer a patient's (or a donor's) cells into living drugs. CAR-T transformed blood-cancer treatment; the frontier is solid tumors, autoimmune indications, and allogeneic ("off-the-shelf") approaches that remove the cost and delay of bespoke manufacturing. Returns hinge on clinical durability, manufacturing scale, and reimbursement for high-price one-time treatments.